These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20496170)

  • 41. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial.
    Dodd N; Carey M; Mansfield E; Oldmeadow C; Evans TJ
    Aust N Z J Public Health; 2019 Oct; 43(5):464-469. PubMed ID: 31268211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for colorectal cancer using the faecal occult blood test, Hemoccult.
    Hewitson P; Glasziou P; Irwig L; Towler B; Watson E
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001216. PubMed ID: 17253456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transition to quantitative faecal immunochemical testing from guaiac faecal occult blood testing in a fully rolled-out population-based national bowel screening programme.
    Clark G; Strachan JA; Carey FA; Godfrey T; Irvine A; McPherson A; Brand J; Anderson AS; Fraser CG; Steele RJ
    Gut; 2021 Jan; 70(1):106-113. PubMed ID: 32234803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reducing income-related inequities in colorectal cancer screening: lessons learned from a retrospective analysis of organised programme and non-programme screening delivery in Winnipeg, Manitoba.
    Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H
    BMJ Open; 2016 Feb; 6(2):e009470. PubMed ID: 26908517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors influencing participation in colorectal cancer screening-a qualitative study in an ethnic and socio-economically diverse inner city population.
    Dharni N; Armstrong D; Chung-Faye G; Wright AJ
    Health Expect; 2017 Aug; 20(4):608-617. PubMed ID: 27550367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of subsequent screening episodes on the positive predictive value for advanced neoplasia and on the distribution of anatomic subsites of colorectal cancer: A population-based study on behalf of the French colorectal cancer screening program.
    Azimafoussé Assogba GF; Jezewski-Serra D; Lastier D; Quintin C; Denis B; Beltzer N; Duport N
    Cancer Epidemiol; 2015 Dec; 39(6):964-71. PubMed ID: 26546750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Institutional (mis)trust in colorectal cancer screening: a qualitative study with Greek, Iranian, Anglo-Australian and Indigenous groups.
    Ward PR; Coffey C; Javanparast S; Wilson C; Meyer SB
    Health Expect; 2015 Dec; 18(6):2915-27. PubMed ID: 25271975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Knowledge, attitude and intentions related to colorectal cancer screening using faecal occult blood tests in a rural Australian population.
    Janda M; Stanton WR; Hughes K; Del Mar C; Clavarino A; Aitken JF; Tong S; Short L; Leggett B; Newman B
    Asia Pac J Public Health; 2003; 15(1):50-6. PubMed ID: 14620498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.
    Dodd N; Mansfield E; Carey M; Oldmeadow C
    Aust N Z J Public Health; 2018 Aug; 42(4):334-339. PubMed ID: 29528551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
    Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Most participate in faecal immunochemical test-based colorectal cancer screening out of curiosity about their chances of developing cancer.
    Denters MJ; Bossuyt PM; Deutekom M; Fockens P; Dekker E
    Eur J Cancer Prev; 2015 May; 24(3):176-9. PubMed ID: 25734239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits.
    Goodwin BC; March S; Ireland M; Crawford Williams F; Manksi D; Ford M; Dunn J
    Rural Remote Health; 2019 Jul; 19(3):4957. PubMed ID: 31340653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the knowledge, behavior and health beliefs of individuals over 50 regarding colorectal cancer screening.
    Tastan S; Andsoy II; Iyigun E
    Asian Pac J Cancer Prev; 2013; 14(9):5157-63. PubMed ID: 24175793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
    Choi KS; Lee HY; Jun JK; Shin A; Park EC
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1070-7. PubMed ID: 22004224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preferences for colorectal cancer screening strategies: a discrete choice experiment.
    Hol L; de Bekker-Grob EW; van Dam L; Donkers B; Kuipers EJ; Habbema JD; Steyerberg EW; van Leerdam ME; Essink-Bot ML
    Br J Cancer; 2010 Mar; 102(6):972-80. PubMed ID: 20197766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.
    Ritvo P; Myers R; Del Giudice ME; Pazsat L; Cotterchio M; Howlett R; Mai V; Brown P; Sullivan T; Rabeneck L
    Can Fam Physician; 2009 Feb; 55(2):176-177.e4. PubMed ID: 19221081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative evaluation of two colorectal cancer screening campaigns using different faecal occult blood tests in a French area.
    Cariou M; El Fettouhi A; Kermarrec T; Bommelaere F; Foll Y; Nousbaum JB; Robaszkiewicz M; Quénéhervé L
    Cancer Epidemiol; 2020 Dec; 69():101839. PubMed ID: 33096500
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An advance notification letter increases participation in colorectal cancer screening.
    Cole SR; Smith A; Wilson C; Turnbull D; Esterman A; Young GP
    J Med Screen; 2007; 14(2):73-5. PubMed ID: 17626705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice.
    Multicentre Australian Colorectal-neoplasia Screening (MACS) Group
    Med J Aust; 2006 Jun; 184(11):546-50. PubMed ID: 16768659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.